A detailed history of Charles Schwab Investment Management Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,035,789 shares of RLAY stock, worth $4.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,035,789
Previous 821,391 26.1%
Holding current value
$4.38 Million
Previous $5.36 Million 36.94%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.23 - $9.51 $1.34 Million - $2.04 Million
214,398 Added 26.1%
1,035,789 $7.33 Million
Q2 2024

Aug 12, 2024

SELL
$5.9 - $8.02 $535,519 - $727,943
-90,766 Reduced 9.95%
821,391 $5.36 Million
Q1 2024

May 08, 2024

BUY
$7.5 - $12.07 $257,580 - $414,532
34,344 Added 3.91%
912,157 $7.57 Million
Q4 2023

Feb 06, 2024

BUY
$6.01 - $11.48 $979,678 - $1.87 Million
163,008 Added 22.8%
877,813 $9.66 Million
Q3 2023

Nov 08, 2023

BUY
$8.24 - $12.97 $349,466 - $550,070
42,411 Added 6.31%
714,805 $6.01 Million
Q2 2023

Aug 09, 2023

BUY
$9.99 - $18.27 $184,934 - $338,214
18,512 Added 2.83%
672,394 $8.45 Million
Q1 2023

May 11, 2023

SELL
$15.0 - $22.76 $8,415 - $12,768
-561 Reduced 0.09%
653,882 $10.8 Million
Q4 2022

Feb 13, 2023

BUY
$14.16 - $24.02 $502,340 - $852,133
35,476 Added 5.73%
654,443 $9.78 Million
Q3 2022

Nov 14, 2022

BUY
$18.07 - $31.37 $1.33 Million - $2.31 Million
73,483 Added 13.47%
618,967 $13.8 Million
Q2 2022

Aug 15, 2022

BUY
$13.31 - $34.88 $11,899 - $31,182
894 Added 0.16%
545,484 $9.14 Million
Q1 2022

May 13, 2022

BUY
$20.26 - $32.36 $335,748 - $536,269
16,572 Added 3.14%
544,590 $16.3 Million
Q4 2021

Feb 11, 2022

BUY
$26.0 - $37.03 $2.59 Million - $3.69 Million
99,696 Added 23.28%
528,018 $16.2 Million
Q3 2021

Nov 16, 2021

BUY
$29.75 - $37.99 $6.11 Million - $7.8 Million
205,352 Added 92.1%
428,322 $13.5 Million
Q2 2021

Aug 16, 2021

BUY
$27.5 - $38.19 $791,422 - $1.1 Million
28,779 Added 14.82%
222,970 $8.16 Million
Q1 2021

May 17, 2021

BUY
$32.52 - $61.53 $1.13 Million - $2.13 Million
34,628 Added 21.7%
194,191 $6.71 Million
Q4 2020

Feb 16, 2021

BUY
$35.51 - $54.03 $160,505 - $244,215
4,520 Added 2.92%
159,563 $6.63 Million
Q3 2020

Nov 13, 2020

BUY
$32.81 - $45.1 $5.09 Million - $6.99 Million
155,043 New
155,043 $6.6 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $509M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.